Back to User profile » Dr Kunihiro Asanuma

Papers published by Dr Kunihiro Asanuma:

Original Research

Clinical Outcome in Soft Tissue Sarcoma Patients with Lung Metastasis Who Received Metastasectomy and/or Radiofrequency Ablation: Tokai Musculoskeletal Oncology Consortium Study

Nakamura T, Asanuma K, Takao M, Yamanaka T, Koike H, Chen-Yoshikawa TF, Tsukushi S, Kuroda H, Kozawa E, Sano M, Aiba H, Nakanishi R, Nagano A, Yamada K, Shido Y, Kawanami K, Izubuchi Y, Sudo A, Nishida Y

Cancer Management and Research 2021, 13:8473-8480

Published Date: 10 November 2021

Original Research

Clinical Outcome of Systemic Treatment for Advanced Soft Tissue Sarcoma: Real-Life Perspective in Japan

Nakamura T, Asanuma K, Hagi T, Sudo A

Drug Design, Development and Therapy 2020, 14:4215-4220

Published Date: 12 October 2020

Original Research

Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology Group

Nakamura T, Sugaya J, Naka N, Kobayashi H, Okuma T, Kunisada T, Asanuma K, Outani H, Nishimura S, Kawashima H, Akiyama T, Yasuda T, Miwa S, Sudo A, Ueda T

Cancer Management and Research 2020, 12:10017-10022

Published Date: 12 October 2020

Original Research

Carbonic anhydrase IX enhances tumor cell proliferation and tumor progression in osteosarcoma

Okuno K, Matsubara T, Nakamura T, Iino T, Kakimoto T, Asanuma K, Matsumine A, Sudo A

OncoTargets and Therapy 2018, 11:6879-6886

Published Date: 12 October 2018

Original Research

Impact of tumor volume doubling time on post-metastatic survival in bone or soft-tissue sarcoma patients treated with metastasectomy and/or radiofrequency ablation of the lung

Nakamura T, Matsumine A, Takao M, Nakatsuka A, Matsubara T, Asanuma K, Sudo A

OncoTargets and Therapy 2017, 10:559-564

Published Date: 31 January 2017